Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Development of [(3)H]2-Carboxy-4,6-dichloro-1H-indole-3-propionic Acid ([(3)H]PSB-12150): A Useful Tool for Studying GPR17.
Systematic reviews in paediatric multiple sclerosis and Creutzfeldt-Jakob disease exemplify shortcomings in methods used to evaluate therapies in rare conditions.
Erratum to: The interrelations between spiritual well-being, pain interference and depressive symptoms in patients with multiple sclerosis.
Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.
Hyperperfusion of Multiple Sclerosis Plaques Characterized by 3D FSE Arterial Spin Labelling.
EDITORIAL Neuroglia as a Central Element of Neurological Diseases: An Underappreciated Target for Therapeutic Intervention.
Dimethyl fumarate for treating relapsing multiple sclerosis.
Multiple sclerosis at menopause: Potential neuroprotective effects of estrogen.
Therapeutic applications of nanomedicine in autoimmune diseases: From immunosuppression to tolerance induction.
The POLG Polyglutamine Tract Variants in Iranian Patients with Multiple Sclerosis.
Pallidal and caudate volumes correlate with walking function in multiple sclerosis.
Promoting Physical Activity through a Manual Wheelchair Propulsion Intervention in Persons with Multiple Sclerosis.
White matter atrophy in brain of neuromyelitis optica: a voxel-based morphometry study.
Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
Evaluation of the Persian version of modified fatigue impact scale in Iranian patients with multiple sclerosis.
Progressive multiple sclerosis does not associate with rs996343 and rs2046748.
Non-protein amino acids and neurodegeneration: The enemy within.
Comments on the review article 'Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades'.
Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes.
Validation of the Serbian Version of Multiple Sclerosis Spasticity Scale 88 (MSSS-88).
Should MRI be the primary endpoint of phase 3 trials in multiple sclerosis?
Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice.
A novel stop mutation in the EDNRB gene in a family with Hirschsprung's disease associated with Multiple Sclerosis.
Clinical and biomarker assessment of demyelinating events suggesting multiple sclerosis.
Clinical applications of diffusion imaging in the spine.
Pages
« first
‹ previous
…
606
607
608
609
610
611
612
613
614
…
next ›
last »